Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Sawyers

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Current Opinion in Genetics & Development|January 16, 2002
Rational therapeutic intervention in cancer: kinases as drug targetsCharles L Sawyers
Genes & Development|January 1, 2004
Opportunities and challenges in the development of kinase inhibitor therapy for cancerCharles L Sawyers
Clinical Advances in Hematology & Oncology : H&O|December 22, 2009
Lessons learned from the development of kinase inhibitorsCharles L Sawyers
The New England Journal of Medicine|June 8, 2010
Even better kinase inhibitors for chronic myeloid leukemiaCharles L Sawyers
Cell|June 4, 2009
Finding and drugging the vulnerabilities of RAS-dependent cancersCharles L Sawyers
Cancer Cell|December 12, 2003
Will mTOR inhibitors make it as cancer drugs?Charles L Sawyers
Nature|October 26, 2007
Cancer: mixing cocktailsCharles L Sawyers
Nature Medicine|October 6, 2007
Where lies the blame for resistance--tumor or host?Charles L Sawyers
The Journal of Clinical Investigation|November 5, 2008
Translational research: are we on the right track? 2008 American Society for Clinical Investigation Presidential AddressCharles L Sawyers
Transactions of the American Clinical and Climatological Association|January 11, 2013
The 2011 Gordon Wilson Lecture: overcoming resistance to targeted cancer drugsCharles L Sawyers
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Current Opinion in Genetics & Development|January 16, 2002
Rational therapeutic intervention in cancer: kinases as drug targetsCharles L Sawyers
Genes & Development|January 1, 2004
Opportunities and challenges in the development of kinase inhibitor therapy for cancerCharles L Sawyers
Clinical Advances in Hematology & Oncology : H&O|December 22, 2009
Lessons learned from the development of kinase inhibitorsCharles L Sawyers
The New England Journal of Medicine|June 8, 2010
Even better kinase inhibitors for chronic myeloid leukemiaCharles L Sawyers
Cell|June 4, 2009
Finding and drugging the vulnerabilities of RAS-dependent cancersCharles L Sawyers
Cancer Cell|December 12, 2003
Will mTOR inhibitors make it as cancer drugs?Charles L Sawyers
Nature|October 26, 2007
Cancer: mixing cocktailsCharles L Sawyers
Nature Medicine|October 6, 2007
Where lies the blame for resistance--tumor or host?Charles L Sawyers
The Journal of Clinical Investigation|November 5, 2008
Translational research: are we on the right track? 2008 American Society for Clinical Investigation Presidential AddressCharles L Sawyers
Transactions of the American Clinical and Climatological Association|January 11, 2013
The 2011 Gordon Wilson Lecture: overcoming resistance to targeted cancer drugsCharles L Sawyers
Pageof 22